A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
Clinical trial NCT07069712 · RECRUITING
Trial details
- NCT number
- NCT07069712
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-17
- Primary completion
- 2027-11-03
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.